SEC 13F Intelligence

Knott David M / LGND

Knott David M’s Ligand Pharmaceuticals Inc Position

Does Knott David M own Ligand Pharmaceuticals Inc (LGND)? Yes75.0K shares worth $10M (+3.80% of its 13F portfolio) as of Q3 2021.

Position Value
$10M
Q3 2021
Shares
75.0K
% of Portfolio
+3.80%
Quarters Held
12
currently held

Position History LGND

Reported value by quarter
Q4 ’18: $47MQ4 ’18Q1 ’19: $43MQ2 ’19: $40MQ2 ’19Q3 ’19: $35MQ4 ’19: $37MQ4 ’19Q1 ’20: $26MQ2 ’20: $31MQ2 ’20Q3 ’20: $24MQ4 ’20: $25MQ4 ’20Q1 ’21: $11MQ2 ’21: $10MQ2 ’21Q3 ’21: $10Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 202175.0K$10M+3.80%
Q2 202175.0K$10M+3.50%
Q1 202175.0K$11M+4.89%
Q4 2020248.0K$25M+11.16%
Q3 2020248.0K$24M+13.87%
Q2 2020273.0K$31M+16.67%
Q1 2020353.0K$26M+16.20%
Q4 2019353.0K$37M+14.92%
Q3 2019353.0K$35M+14.76%
Q2 2019353.0K$40M+17.00%
Q1 2019344.0K$43M+17.24%
Q4 2018344.0K$47M+21.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Knott David M’s full portfolio or all institutional holders of LGND.